|52Wk High:||52Wk Low:|
BioDelivery Sciences International Inc. is a specialty pharmaceutical company focused in the areas of pain management and addiction medicine. The company utilizes its novel and proprietary BioErodible MucoAdhesive and other drug delivery technologies to develop and commercialize, either on its own or in partnership with third parties, new applications of proven therapies aimed at addressing important unmet medical needs. The company's development strategy focuses on utilization of the FDA's 505(b)(2) approval process. This regulatory pathway allows BioDelivery Sciences to potentially obtain more timely and efficient approval of new formulations of previously approved therapeutics.